MRK's Winrevair hits its phase II goal in patients with CpcPH tied to HFpEF, setting up phase III plans and a potential path to broader use. Stock up.

MRK's Winrevair hits its phase II goal in patients with CpcPH tied to HFpEF, setting up phase III plans and a potential path to broader use. Stock up.

Agios slides to a 52-week low after mixed phase III RISE UP data show a hemoglobin boost but no significant cut in pain crises.

Agios slides to a 52-week low after mixed phase III RISE UP data show a hemoglobin boost but no significant cut in pain crises.

Seventh Independent Data Monitoring Committee review completed for Dimerix’s ACTION3 phase III kidney disease study. ...

Seventh Independent Data Monitoring Committee review completed for Dimerix’s ACTION3 phase III kidney disease study. ...

INSM climbs after the EU clears Brinsupri as the first approved treatment for NCFB, backed by phase III ASPEN and phase II WILLOW results.

INSM climbs after the EU clears Brinsupri as the first approved treatment for NCFB, backed by phase III ASPEN and phase II WILLOW results.

Alzheimer’s disease is the most common cause of dementia, slowly robbing millions of people around the world of their memory and independence. For...

Alzheimer’s disease is the most common cause of dementia, slowly robbing millions of people around the world of their memory and independence. For...